Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01650519 · ClinicalTrials.gov registry record · Phase 4
A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery
A Phase 4 study, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 51
- Enrollment target
NCT01650519 is a Phase 4 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 51 participants.
The verdict
NCT01650519, a Phase 4 study, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 51 participants
- Enrollment target
Study Summary
The intent of this study is to assess the analgesic efficacy of IV ibuprofen when administered at induction of anesthesia. Results from this pilot study will be used to design and determine the appropriate statistical power for a larger, multi-center randomized study.
Interventions
- DRUG IV ketorolac
- DRUG IV ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01650519
The ClinicalTrials.gov registry entry for NCT01650519 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IV ketorolac is the first listed.
NCT01650519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01650519 about?
NCT01650519 is a clinical study titled "A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery". The intent of this study is to assess the analgesic efficacy of IV ibuprofen when administered at induction of anesthesia. Results from this pilot study will be used to design and determine the appropriate statistical power for a larger, multi-center randomized study.
What is the current status of trial NCT01650519?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2012-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01650519?
The interventions under investigation include: IV ketorolac (DRUG), IV ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01650519?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.